Диссертация (1139544), страница 42
Текст из файла (страница 42)
2005.Vol.184.P.295–307.159. Eichholzer M. Is low or high body weight associated with an increased riskof neural tube defects? Praxis (Bern 1994). 2006.Vol. 20;95(51-52).P.2019-26.160. Elhenicky M., Distelmaier K., Mailath-Pokorny M. Abnormal maternalechocardiographicfindingsintripletpregnanciespresentingwithdyspnoea.Wien Klin Wochenschr.
2016. Feb. Р. 25.161. Elmekkawi S.F., Mansour G.M., Elsafty M.S.Prediction of FetalHypertrophic Cardiomyopathy in Diabetic Pregnancies Compared withPostnatal Outcome.Clin Med Insights Womens Health. 2015 Dec 1;8:39-43.doi: 10.4137/CMWH.S32825.162. Erkoc M.F., Okur A., Kara M. Hepatic vein and portal vein Dopplerultrasound of maternal liver in normal pregnancy. Matern.
Fetal. Neonatal.Med. 2015.V. 23.P.1-4.163. ESHRE Capri Workshop Group. Nutrition and reproduction in women. HumReprod Update. 2006 May-Jun;12(3):193-207. Epub 2006 Jan 31.164. Ferezou-Viala J, Roy A-f, Serougne C, Gripois D, Parquet M, et al.
Longterm consequences of maternal high-fat feeding on hypothalamic leptinsensitivity and diet-induced obesity in the offspring. Am J Physiol RegulIntegr Comp Physiol. 2007.Vol.293P.R1056–1062.165. Ferreira H.S., Moura F.A. Short stature of mothers from an area endemic forundernutrition is associated with obesity, hypertension and stunted children: a251population-based study in the semi-arid region of Alagoas, Northeast Brazil.BrJ Nutr. 2009.Vol.101(8).P.1239-45.166. Fiala J.E., Egan J.F., Lashgari M.
The influence of body mass index onpregnancy outcomes. Conn Med. 2006.Vol.70(1).P.21–23.167. Fiore G., Florio P., Micheli L. Endothelin-1 triggers placental oxidativestress pathways: putative role in preeclampsia. J. Clin. Endocrinol. Metab .2005.Vol.90.P.4205–4210168. Gadonski G, LaMarca BB, Sullivan E, Bennett W, Chandler D, Granger JP.Hypertension produced by reductions in uterine perfusion in the pregnant rat:role of interleukin 6.
Hypertension 2006.Vol.48.P. 711–716169. Gale S.M., Castrancone D., Mantzoros C.S. Energy homeostasis, obesity andeatingdisorders;recentadvancesinendocrinology.JNutr2004.Vol.134.P.295–298.170. Ganzevoort W., Rep A., Bonsal G.J. A randomised controlled trialcomparing two temporising management strategies, one with and one withoutplasma volume expansion, for severe and early onset pre-eclampsia. BJOG.2005.Vol.112.P.1358–1368.171. Gardiner P.M., Nelson L.
The clinical content of preconception care:nutrition and dietary supplements. Am J Obstet Gynecol.2008.Vol.199(6Suppl 2).P.S345-56.172. Ghi T., degli Esposti D., Montaguti E. Maternal cardiac evaluation duringuncomplicated twin pregnancy with emphasis on the diastolic function. Am J.Obstet Gynecol.2015Sep;213(3):376.e1-8.doi: 10.1016173. Giannico A.T., Gil E.M., Garcia D.A.Canine fetal echocardiography:correlations for the analysis of cardiac dimensions.Vet Res Commun.
2016Mar;40(1):11-9. doi: 10.1007/s11259-015-9648-z.174. Gigante D.P., Rasmussen K.M., Pregnancy increases BMI in adolescents ofa population-based birth cohort. J. Nutr. 2005..Vol.135(1).P.74-80.175. GilbertJ.S.,RyanM.J.Pathophysiologyofhypertensionduringpreeclampsia: linking placental ischemia with endothelial dysfunction.//252American Journal Physiology Heart Circulatory Physiology. 2011.Vol. 294.N2.-P.541-550.176.
GilbertJ.S.,RyanM.J.Pathophysiologyofhypertensionduringpreeclampsia: linking placental ischemia with endothelial dysfunction. Am JPhysiol Heart Circ Physiol.2008.Vol.294(2).P.H541-50.177. Granger J.P., LaMarca B.B., Cockrell K. Reduced uterine perfusion pressure(RUPP) model for studying cardiovascular-renal dysfunction in response toplacental ischemia. Methods Mol Med 2006.Vol.122.P.383–392178. Grandi C., Luchtenberg G,. Nutrition assessment during pregnancy. A newweight chart Medicina (B Aires). 2007.Vol.67(6 Pt 2).P.677-84.179. Guelinckx I, Devlieger R, Beckers K, Vasant G.
Maternal obesity:pregnancy complications, gestational weight gain and nutrition. Obes Rev.2008.Vol.9(2).P.140–50.180. Gu Y, Lewis DF, Wang Y. Placental productions and expressions of solubleendoglin, soluble fms-like tyrosine kinase receptor-1, and placental growthfactor in normal and preeclamptic pregnancies. J Clin Endocrinol Metab.2008.Vol.93(1).P.260–6.181. Hannukainen J., Guzzardi M., Imaging of Organ Metabolism in Obesity andDiabetes: Treatment Perspectives/ CurrationPharmacology Desease.-2014.Vol. 17.
P.1347–1352.182. Haukkamaa L, Moilanen L, Kattainen A Pre-eclampsia is a risk factor ofcarotid artery atherosclerosis. Cerebrovasc Dis.2009.Vol27(6).P.599-607.183. Heindel JJ, vom Saal FS Role of nutrition and environmental endocrinedisrupting chemicals during the perinatal period on the aetiology ofobesity.Mol Cell Endocrinol. 2009 .Vol.304(1-2).P.:90-96.184. Heitmann B.L.
The importance of gender of patients and generalpractitioners in relation to treatment practices for overweight./ PLoS One. 2014 .№ 22;9(4).Р.95706.253185. Hilfiker-Kleiner D., Haghikia A., Nonhoff J. Peripartum cardiomyopathy:current management and future perspectives. Eur Heart J. 2015 May7;36(18):1090-7. doi: 10.1093186.
Hirshfeld-Cytron J., Lam C., Karumanchi S.A., Late postpartum eclampsia:examples and review. Obstet Gynecol Surv. 2006.Vol.61. P.471–80.187. Hughes E.C..Working group report on high blood pressure in pregnancy.Am. J. Obstet. Gynecol. 1990.V.163.P.1691-712.188. Hussein W., Lafayette R.A. Renal function in normal and disorderedpregnancy. Curr. Opin. Nephrol. Hypertens. 2014 .Vol.23(1).P.46-53.189. Huynh L., McCoy M., Law A.
Systematic literature review of the costs ofpregnancy in the US. Pharmacoeconomics. 2013. Vol.31(11).P.1005-1030190. Kaaja R. Delmis J. Predictors and risk factors of pre-eclampsia. MinervaGinecol. 2008.Vol. 60(5).P.421-429.191. Itoh H. Programs for continuing medical education: B session; 6. Metabolicsyndrome and chronic kidney disease. Nihon Naika Gakkai Zasshi. 2014.Vol.103(3).P.
710-716.192. Karumanchi SA, Lindheimer MD. Advances in Understanding of eclampsia.Current Hypertension Reports. 2008.Vol.10.P.305–312.193. Karumanchi S.A., Maynard SE, Stillman I.E. Preeclampsia: a renalperspective. Kidney Int. 2005.Vol.67.P.2101–2113194. Kershaw E.E. and Flier J.S. Adipose tissue as an endocrine organ. J Clin.Endocrinol. Metab.2004.V. 89.P.2548–2556.195.
Khalil A, Jauniaux E, Antihypertensive therapy and central hemodynamicsinwomenwithhypertensivedisordersinpregnancy.ObstetGynecol.2009.Vol.113(3).P.646-54.196. Khan K., Woidylo P., Say L., van Look PFA. WHO analysis of causes ofmaternal death: a review. Lancet. 2006.Vol.367.P.1066–1074.197. Konno S.C., Benicio D.', Aquino M..H Factors associated to the evolution ofgestational weight of pregnant women: a multilevel analysis Rev SaudePublica. 2007.Vol. 41(6).P.995-1002.254198. Konta T. Renal disease-related clinical examination in a cohort study.Rinsho Byori.
2014.Vol. 62(2).P. 190-196.199. Laraia BA, Bodnar LM. Pregravid body mass index is negatively associatedwith diet quality during pregnancy.Public Health Nutr. 2007.Vol.10(9).P.920926.200. LeemanM.ArterialhypertensioninpregnancyRevMedBrux.Sep.2008.Vol.29(4).P.340-345201. Levine RJ, Lam C, Qian C, Yu KF, Maynard SE, et al. Soluble endoglin andother circulating antiangiogenic factors in preeclampsia. N Engl J Med.2006.Vol.355.P.992–1005.202. Li H, Gu B, Zhang Y, Lewis DF, Wang Y. Hypoxia-induced increase insoluble Flt-1 production correlates with enhanced oxidative stress introphoblast cells from the human placenta. Placenta.
2005.Vol.26(2–3).P.210–217.203. Li Y., Zhu S., Li B., Shao X. Association between non-alcoholic fatty liverdisease and chronic kidney disease in population with prediabetes or diabetes.Int. Urol. Nephrol. 2014. V.46(9).P.1785-91. doi: 10.1007/s11255-014-07969.204. Lithgow D., Nyamathi A. C-reactive protein in nipple aspirate fluid: relationto women's health factors. Nurs Res. 2006.Vol. Nov-Dec;5(6).P.418-25.205. Liu Y.H., Liu J.M., Liu L.
The relationship between prepregnancy bodymass index and the occurrence of pregnancy induced hypertension 18,5 XueZa Zhi. 2009.Vol.43(4).P.299-304.206. Li Z., Zhang Y., Ying Ma J. Recombinant vascular endothelial growth factor121 attenuates hypertension and improves kidney damage in a rat model ofpreeclampsia. Hypertension 2007.Vol.50.P.686–692207. Llinas M., Wallukat G., Dechend R. Agonistic autoantibodies to the AT1receptor in a rat model of preeclampsia induced by chronic reductions inuterineperfusion2005.Vol.46.P.884pressure(RUPP)(Abstract).Hypertension255208. Lu F., Longo M., Tamayo E.
The effect of over-expression of sFlt-1 onblood pressure and the occurrence of other manifestations of preeclampsia inunrestrainedconsciouspregnantmice.Am.J.Obstet.Gynecol.2007.Vol.196.P.e1–e7209. Makris A., Thornton C., Thompson J, Thomson S, Martin R, et al.Uteroplacental ischemia results in proteinuric hypertension and elevatedsFLT-1. Kidney Int. 2007.Vol.71(10)P.977–84.210.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
